
Enhanced Group posts $62 million loss after costly Enhanced Games
The telehealth firm’s second-quarter results reveal that the Las Vegas sports event, which permitted performance-enhancing drugs, was a commercial failure, prompting a pivot to a lower-cost online series.






































